BioNTech chief calls for speedy ruling on Covid vaccines that target latest strains
‘Time is ticking’ as studies suggest original Omicron jabs may not offer strong protection against sub-variants
https://www.ft.com/content/1c1bcc16-afe6...ee925f7f75
‘Time is ticking’ as studies suggest original Omicron jabs may not offer strong protection against sub-variants
https://www.ft.com/content/1c1bcc16-afe6...ee925f7f75